pharmaphorum

MAY 26, 2022

Cumulus Neuroscience has started a pair of clinical trials to gauge the value of a panel of physiological and digital biomarkers in tracking the course of neurodegenerative diseases, including Alzheimer’s. The hope is that the toolkit will improve on current measurement tools for dementia and other neurological conditions that have serious limitations, according to the Northern Ireland company’s chief scientific officer Brian Murphy.

FDA 59

FDA 59

Pharma Times

MAY 26, 2022

Approval provides another step forward in transforming multiple myeloma outcomes and eliminating the disease

52

52

SingleCare

MAY 26, 2022

With the cost of living on the rise, having a steady income is crucial. But sometimes even regular employment doesn’t cover all of the outgoing expenses you might have—which are often multiplied if you’re living in a city or expensive area. Just like many other professions, pharmacy technicians might be feeling the financial squeeze right now.

Community Pharmacies 52

Community Pharmacies Long-Term Care Facilities Hospitals 52

Pharmig

MAY 26, 2022

Everyone wants to know where they come from, and microbiologists are no different. But were we grown in a petri dish. The post Events and training for pharmaceutical microbiologists 2022 appeared first on Pharmig.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

MAY 26, 2022

For years, key opinion leaders (KOLs) have held a position of authority and respect amongst those working across the life science industry, be it a result of their expertise in a specific therapeutic area, notable experience working in a particular field, or their connections with researchers, decision-makers, and patients. In a traditional setting, where face-to-face interactions are prioritised, identifying KOLs is relatively straightforward.

Hospitals 52

Hospitals 52

Pharma Times

MAY 26, 2022

Libtayo has been approved for adults when curative surgery or radiation is not appropriate

49

49

Pharma Manufacturing

MAY 26, 2022

While change does not always happen quickly in the pharma industry, the ongoing global pandemic has quickened the pace of emerging trends.

45

45

pharmaphorum

MAY 26, 2022

Eli Lilly’s home state of Indiana is set to benefit from a massive $2.1 billion investment by the pharma group, earmarked for two brand new manufacturing facilities. The two plants will both be located at the LEAP Lebanon Innovation and Research District in Boone County, a few miles to the north west of Lilly’s headquarters in the Hoosier state capital Indianapolis.

FDA 52

FDA 52

Pharma Manufacturing

MAY 26, 2022

With utility costs on the rise, many pharma manufacturers are taking a closer look at their facilities and finding that better facility design, resource management and maintenance strategies can offer sources of overlooked savings, as well as opportunities for sustainability.

40

40

pharmaphorum

MAY 26, 2022

Servier is on course to get a return on its $1.8 billion takeover of Agios Pharma’s oncology business after getting a key FDA approval for Tibsovo, the main asset in the deal. The US regulator has approved Tibsovo (ivosidenib) in combination with Bristol-Myers Squibb’s chemotherapy Vidaza (azacitidine) as a first-line therapy for IDH1-mutated acute myeloid leukaemia (AML), expanding the eligible patient population for the drug.

FDA 52

FDA Chemotherapy Labelling 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Manufacturing

MAY 26, 2022

New, complex therapies coming through the pharma pipelines are putting immense pressure on supply chains and manufacturing capacity, challenging traditional scale-up and manufacturing processes at the same time — and CDMOs have stepped up into the thick of it all.

40

40

pharmaphorum

MAY 26, 2022

The co-founder of Los Angeles biotech Enochian Biosciences has been arrested in connection with a federal investigation into the murder of a Vermont man in 2018. Serhat Gümrükcü (39) has been charged with conspiring to use interstate commerce facilities in the commission of murder-for-hire, along with alleged co-conspirator Berk Eratay (35) of Las Vegas.

Chemotherapy 106

Chemotherapy 106

The Spirit Pharmacist

MAY 26, 2022

In this video blog I wanted to address the pharmacologic mechanisms of 5-MeO-DMT in reference to classic psychedelic tryptamines like LSD, psilocybin, and DMT. Psychedelic Tryptamines are Serotonin 2A Stimulating Substances. A common feature of all psychedelic tryptamines is their ability to bind and stimulate serotonin 2A (5HT2A) receptors. Experiments that pre-treat persons or rodents with 5HT2A receptor blocking antipsychotic medications have all demonstrated that psychedelic effects are grea

Packaging 52

Packaging 52

pharmaphorum

MAY 26, 2022

In the diverse world we live in, the products we produce, the services we create and the places we work should be as equally representative. In recent years this has seen diversity, equity, and inclusion (DEI) become a big focus for industries to get right. Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening.

Packaging 143

Packaging Vaccines Generic Medicine Compounding 143

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA